EPIDERMOLYSIS BULLOSA DYSTROPHICA
Clinical trials for EPIDERMOLYSIS BULLOSA DYSTROPHICA explained in plain language.
Never miss a new study
Get alerted when new EPIDERMOLYSIS BULLOSA DYSTROPHICA trials appear
Sign up with your email to follow new studies for EPIDERMOLYSIS BULLOSA DYSTROPHICA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Custom skin patch offers hope for rare blistering condition
Disease control OngoingThis study tests a lab-made skin substitute on one patient with dystrophic epidermolysis bullosa, a rare disease causing fragile skin and chronic wounds. The goal is to see if the graft can reduce wound size and pain. It is an early-stage, single-patient trial, not a cure.
Matched conditions: EPIDERMOLYSIS BULLOSA DYSTROPHICA
Phase: EARLY_PHASE1 • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
AI app aims to catch deadly skin cancer early in rare disease patients
Diagnosis OngoingThis study is developing an artificial intelligence app to detect squamous cell carcinoma (a type of skin cancer) in people with recessive dystrophic epidermolysis bullosa (RDEB), a rare genetic blistering condition. Twenty adults with RDEB and a history of skin cancer will submi…
Matched conditions: EPIDERMOLYSIS BULLOSA DYSTROPHICA
Sponsor: Northwestern University • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC
-
Turmeric and blue light may heal blisters in rare skin disease
Symptom relief OngoingThis study tests whether a gel made from curcumin (the active part of turmeric) combined with blue LED light can heal painful mouth blisters in people with epidermolysis bullosa, a rare condition that makes skin and mucous membranes extremely fragile. Twenty participants will rec…
Matched conditions: EPIDERMOLYSIS BULLOSA DYSTROPHICA
Phase: PHASE4 • Sponsor: Universidade Ceuma • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC